The primary endpoint for the EMA was the percentage of patients achieving a SALT 10 at week 24, and the key secondary endpoint was improvement in the Patient's Global Impression of Change (PGI-C), defined as a rating of moderately improved or much improved at week 24 (PGI-C: a 7-point patient scale ranging from very much improved to very much worse).8 Baseline demographic and disease characteristics were balanced among treatment groups: 15% of patients were adolescents, 62% were women, 68% were White, and 46% had AT or AU
The amount and how often you get the shots can change based on your needs
Ozempic is a once-weekly injection, requiring monitoring for gastrointestinal tolerance and rare pancreatitis (see Ozempic prescribing information )
After missing a dose, many users report feeling impulsive, reactive, or out of sync emotionally
According to the SmPC, no dose adjustment is required for patients with mild to moderate renal or hepatic impairment, as pharmacokinetic changes across these populations are not clinically relevant, but use is not recommended in cases of severe renal or hepatic impairment due to limited experience